The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040
Open accessAbstract
Importance: Despite many cases being preventable, cutaneous melanoma remains the most serious skin cancer worldwide. Understanding the scale and profile of the disease is vital to concentrate and reinforce global prevention efforts. Objective: To examine global patterns of cutaneous melanoma in 2020 and to provide projected estimates of cases and deaths by 2040. Design, Setting, and Participants: This population-based study used the GLOBOCAN 2020 database for global epidemiological assessment of new cases and deaths due to invasive melanoma. Main Outcomes and Measures: Age-standardized incidence and mortality rates were calculated per 100 000 person-years by country, world region, and 4-tier level of human development. Estimated numbers of cases and deaths were calculated for the year 2040. Results: A worldwide total of 325 000 new melanoma cases (174 000 males, 151 000 females) and 57 000 deaths (32 000 males, 25 000 females) was estimated for 2020. Large geographic variations existed across countries and world regions, with the highest incidence rates among males (42 per 100 000 person-years) and females (31 per 100 000 person-years) observed in Australia/New Zealand, followed by Western Europe (19 per 100 000 person-years for males and females), North America (18 per 100 000 person-years for males, 14 per 100 000 person-years for females), and Northern Europe (17 per 100 000 person-years for males, 18 per 100 000 person-years for females). Melanoma continued to be rare in most African and Asian countries, with incidence rates commonly less than 1 per 100 000 person-years. Mortality rates peaked at 5 per 100 000 person-years in New Zealand, and geographic variations were less pronounced than for incidence. Melanoma was more frequent among males than females in most world regions. If 2020 rates continue, the burden from melanoma is estimated to increase to 510 000 new cases (a roughly 50% increase) and to 96 000 deaths (a 68% increase) by 2040. Conclusions and Relevance: This epidemiological assessment suggests that melanoma remains an important challenge to cancer control and public health globally, especially in fair-skinned populations of European descent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Self-citationCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Self-citationEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Self-citationSiegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Self-citationAllemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145
Self-citationCancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Cancer statistics for the year 2020: An overview
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021) · International Journal of Cancer · doi:10.1002/ijc.33588 · Cited by 5,689
Self-citationUnited Nations Statistics Division
(2006) · Choice Reviews Online · doi:10.5860/choice.43sup-0473 · Cited by 1,202
Valverde, P., Healy, E., Jackson, I., Rees, J. L., & Thody, A. J. (1995) · Nature Genetics · doi:10.1038/ng1195-328 · Cited by 999
A review of human carcinogens--part D: radiation
El Ghissassi, F., Baan, R., Straif, K., Grosse, Y., Secretan, B., Bouvard, V., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70213-x · Cited by 900
Cancer mortality for selected sites in 24 countries
栗原, 登., & 瀬木, 三. (1960) · Medical Entomology and Zoology · Cited by 871
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
Zuo, L., Weger, J., Yang, Q., Goldstein, A. M., Tucker, M. A., Walker, G. J., Hayward, N., & Dracopoli, N. C. (1996) · Nature Genetics · doi:10.1038/ng0196-97 · Cited by 818
Gandini, S., Sera, F., Cattaruzza, M. S., Pasquini, P., Zanetti, R., Masini, C., Boyle, P., & Melchi, C. F. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.03.034 · Cited by 787
Whiteman, D. C., Green, A. C., & Olsen, C. M. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.01.035 · Cited by 628
Self-citationErdmann, F., Lortet‐Tieulent, J., Schüz, J., Zeeb, H., Greinert, R., Breitbart, E. W., & Bray, F. (2013) · International Journal of Cancer · doi:10.1002/ijc.27616 · Cited by 627
Self-citationEmerging cancer trends among young adults in the USA: analysis of a population-based cancer registry
Sung, H., Siegel, R. L., Rosenberg, P. S., & Jemal, A. (2019) · The Lancet Public Health · doi:10.1016/s2468-2667(18)30267-6 · Cited by 618
Human Development Report 2020: The Next Frontier - Human Development and the Anthropocene
United Nations Development Programme (2020) · Human Development Report · doi:10.18356/9789210055161 · Cited by 594
Fidler, M. M., Gupta, S., Soerjomataram, I., Ferlay, J., Steliarova-Foucher, E., & Bray, F. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30677-0 · Cited by 579
Self-citationHow much melanoma is caused by sun exposure?
Armstrong, B. K., & Kricker, A. (1993) · Melanoma Research · doi:10.1097/00008390-199311000-00002 · Cited by 530
Predicting the future burden of cancer
Bray, F., & Møller, B. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1781 · Cited by 486
Self-citationGoldstein, A. M., Chan, M., Harland, M., Gillanders, E. M., Hayward, N. K., Avril, M.-F., Azizi, E., Bianchi-Scarra, G., Bishop, D. T., Bressac-de Paillerets, B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0494 · Cited by 426
The Rapid Rise in Cutaneous Melanoma Diagnoses
Welch, H. G., Mazer, B. L., & Adamson, A. S. (2021) · New England Journal of Medicine · doi:10.1056/nejmsb2019760 · Cited by 418
Cutaneous malignant melanoma in Europe
de Vries, E., & Willem Coebergh, J. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.06.003 · Cited by 266
Self-citationKhair, D. O., Bax, H. J., Mele, S., Crescioli, S., Pellizzari, G., Khiabany, A., Nakamura, M., Harris, R. J., French, E., Hoffmann, R. M., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00453 · Cited by 245
Landi, M. T., Bishop, D. T., MacGregor, S., Machiela, M. J., Stratigos, A. J., Ghiorzo, P., Brossard, M., Calista, D., Choi, J., Fargnoli, M. C., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0611-8 · Cited by 232
Self-citationAge-Specific Incidence of Melanoma in the United States
Paulson, K. G., Gupta, D., Kim, T. S., Veatch, J. R., Byrd, D. R., Bhatia, S., Wojcik, K., Chapuis, A. G., Thompson, J. A., Madeleine, M. M., et al. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2019.3353 · Cited by 229
Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015
Arnold, M., Holterhues, C., Hollestein, L. M., Coebergh, J. W. W., Nijsten, T., Pukkala, E., Holleczek, B., Tryggvadóttir, L., Comber, H., Bento, M. J., et al. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12236 · Cited by 222
Self-citationTrends in incidence of thick, thin and in situ melanoma in Europe
Sacchetto, L., Zanetti, R., Comber, H., Bouchardy, C., Brewster, D. H., Broganelli, P., Chirlaque, M. D., Coza, D., Galceran, J., Gavin, A., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2017.12.024 · Cited by 210
Brunssen, A., Waldmann, A., Eisemann, N., & Katalinic, A. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.07.045 · Cited by 191
Olsen, C. M., Wilson, L. F., Green, A. C., Bain, C. J., Fritschi, L., Neale, R. E., & Whiteman, D. C. (2015) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.12470 · Cited by 190
Self-citationGlobal burden of cutaneous melanoma attributable to ultraviolet radiation in 2012
Arnold, M., de Vries, E., Whiteman, D. C., Jemal, A., Bray, F., Parkin, D. M., & Soerjomataram, I. (2018) · International Journal of Cancer · doi:10.1002/ijc.31527 · Cited by 183
Self-citationWhiteman, D. C., Baade, P. D., & Olsen, C. M. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.452 · Cited by 174
Self-citationEpidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943–2036
Garbe, C., Keim, U., Gandini, S., Amaral, T. M. S., Katalinic, A., Hollezcek, B., Martus, P., Flatz, L., Leiter, U., & Whiteman, D. C. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.04.029 · Cited by 174
Self-citationNew Systematic Therapies and Trends in Cutaneous Melanoma Deaths Among US Whites, 1986–2016
Berk-Krauss, J., Stein, J. A., Weber, J., Polsky, D., & Geller, A. C. (2020) · American Journal of Public Health · doi:10.2105/ajph.2020.305567 · Cited by 173
Sex and Gender Disparities in Melanoma
Bellenghi, M., Puglisi, R., Pontecorvi, G., Feo, A. D., Carè, A., & Mattia, G. (2020) · Cancers · doi:10.3390/cancers12071819 · Cited by 171
Evaluation of Sex-Specific Incidence of Melanoma
Olsen, C. M., Thompson, J. F., Pandeya, N., & Whiteman, D. C. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.0470 · Cited by 141
Self-citationAnalysis of Trends in US Melanoma Incidence and Mortality
Glazer, A. M., Winkelmann, R. R., Farberg, A. S., & Rigel, D. S. (2016) · JAMA Dermatology · doi:10.1001/jamadermatol.2016.4512 · Cited by 136
Iannacone, M. R., & Green, A. C. (2014) · Melanoma Management · doi:10.2217/mmt.14.6 · Cited by 123
Practical implications of imposing a new world standard population
Bray, F., Guilloux, A., Sankila, R. J., & Parkin, D. M. (2002) · Cancer Causes & Control · doi:10.1023/a:1014344519276 · Cited by 120
Self-citationMelanoma incidence and mortality in Scotland 1979–2003
for and on behalf of the Scottish Melanoma Group, Mackie, R. M., Bray, C. A., Vestey, J. P., Doherty, V. R., Evans, A. T., Thomson, D., & Nicolson, M. C. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603801 · Cited by 118
Waldmann, A., Nolte, S., Weinstock, M. A., Breitbart, E. W., Eisemann, N., Geller, A. C., Greinert, R., Volkmer, B., & Katalinic, A. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.22 · Cited by 109
Invasive cutaneous malignant melanoma in Sweden, 1990–1999
Lindholm, C., Andersson, R., Dufmats, M., Hansson, J., Ingvar, C., Möller, T., Sjödin, H., Stierner, U. K., Wagenius, G., & for the Swedish Melanoma Study Group (2004) · Cancer · doi:10.1002/cncr.20602 · Cited by 108
Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990–2006
Baade, P. D., Meng, X., Youlden, D. R., Aitken, J. F., & Youl, P. (2011) · International Journal of Cancer · doi:10.1002/ijc.25996 · Cited by 91
Etiologic and Other Factors Predicting Nevus-Associated Cutaneous Malignant Melanoma
Purdue, M. P., From, L., Armstrong, B. K., Kricker, A., Gallagher, R. P., McLaughlin, J. R., Klar, N. S., Marrett, L. D., & for the Genes, E. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0097 · Cited by 81
Melanoma burden and recent trends among non-Hispanic whites aged 15–49 years, United States
Watson, M., Geller, A. C., Tucker, M. A., Guy, G. P., & Weinstock, M. A. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.08.032 · Cited by 65
The burden of cutaneous melanoma and status of preventive measures in Central and South America
de Vries, E., Sierra, M. S., Piñeros, M., Loria, D., & Forman, D. (2016) · Cancer Epidemiology · doi:10.1016/j.canep.2016.02.005 · Cited by 50
van der Leest, R. J. T., Zoutendijk, J., Nijsten, T. E. C., Mooi, W. J., van der Rhee, J. I., de Vries, E., & Hollestein, L. M. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.09.008 · Cited by 46
Current and emerging systemic therapies for cutaneous metastatic melanoma
Mason, R., Au, L., Garces, A. I., & Larkin, J. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1601700 · Cited by 46
Long‐term deaths from melanoma according to tumor thickness at diagnosis
Baade, P. D., Whiteman, D. C., Janda, M., Cust, A. E., Neale, R. Ε., Smithers, B. M., Green, A. C., Khosrotehrani, K., Mar, V. J., Soyer, H. P., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32930 · Cited by 45
Self-citationCancer Incidence in Five Continents. Cumulative rate and cumulative risk.
Day, N. E. (1992) · PubMed · Cited by 41
Herbert, A., Koo, M. M., Barclay, M., Greenberg, D. C., Abel, G., Levell, N. J., & Lyratzopoulos, G. (2018) · Melanoma Research · doi:10.1097/cmr.0000000000000489 · Cited by 27
Trends in Incidence and Mortality of Skin Melanoma in Lithuania 1991–2015
Dulskas, A., Čerkauskaitė, D., Vincerževskienė, I., & Urbonas, V. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18084165 · Cited by 13
Cited by
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Shi, Q., Xue, C., Zeng, Y., Yuan, X., Chu, Q., Jiang, S., Wang, J., Zhang, Y., Zhu, D., & Li, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01828-x · Cited by 401
Chesney, J., Lewis, K. D., Kluger, H., Hamid, O., Whitman, E., Thomas, S., Wermke, M., Cusnir, M., Domingo-Musibay, E., Phan, G. Q., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005755 · Cited by 359
Overview of skin cancer types and prevalence rates across continents
Roky, A. H., Islam, M. M., Ahasan, A. M. F., Mostaq, M. S., Mahmud, M. Z., Amin, M. N., & Mahmud, M. A. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2024.08.002 · Cited by 239
Exosome-based immunotherapy as an innovative therapeutic approach in melanoma
Babaei, S., Fadaee, M., Abbasi-kenarsari, H., Shanehbandi, D., & Kazemi, T. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01906-1 · Cited by 48
Skin cancer in Europe today and challenges for tomorrow
Brochez, L., Volkmer, B., Hoorens, I., Garbe, C., Röcken, M., Schüz, J., Whiteman, D. C., Autier, P., Greinert, R., & Boonen, B. (2025) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.20368 · Cited by 33
Self-citation
Metadata
- Authors
- Arnold, M., Singh, D., Laversanne, M., Vignat, J., Vaccarella, S., Meheus, F., Cust, A. E., de Vries, E., Whiteman, D. C., & Bray, F.
- Venue
- JAMA Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2022-05-01
- Volume
- 158
- Issue
- 5
- Pages
- 495
- ISSN
- 2168-6068 (ISSN-L)
- OpenAlex
- W4220856798
- Cited by
- 1,484
- References
- 53
- FWCI
- 104.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.